
National Research Corporation NRC
€ 17.09
0.96%
Quartalsbericht 2025-Q3
hinzugefügt 07.11.2025
National Research Corporation EV 2011-2026 | NRC
EV Jährlich National Research Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.08 B | 1.17 B | 1.08 B | 1.17 B | 1.78 B | 1.14 B | 901 M | 421 M | 378 M | 337 M | 391 M | 35 M | 37 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.78 B | 35 M | 763 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
223 M | $ 24.59 | 6.4 % | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 39.6 | 0.66 % | $ 1.1 B | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 23.95 | 2.79 % | $ 258 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
DexCom
DXCM
|
52.4 B | $ 70.7 | 4.9 % | $ 27.3 B | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 6.01 | -2.91 % | $ 176 M | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Guardant Health
GH
|
6.94 B | $ 104.68 | -4.98 % | $ 12.8 B | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.6 | 0.95 % | $ 2.03 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Illumina
ILMN
|
15.3 B | $ 143.1 | 1.44 % | $ 22.8 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
IQVIA Holdings
IQV
|
54.8 B | $ 239.3 | -1.3 % | $ 43.4 B | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Lantheus Holdings
LNTH
|
6.44 B | $ 66.68 | -1.3 % | $ 4.61 B | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Medpace Holdings
MEDP
|
10.8 B | $ 599.14 | 0.7 % | $ 18.5 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
644 M | $ 20.14 | 17.57 % | $ 1.08 B | ||
|
Danaher Corporation
DHR
|
150 B | $ 237.36 | -0.42 % | $ 174 B | ||
|
Celcuity
CELC
|
506 M | $ 103.34 | -3.88 % | $ 4.08 B | ||
|
ENDRA Life Sciences
NDRA
|
864 K | $ 4.52 | -2.8 % | $ 2.43 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Natera
NTRA
|
5.53 B | $ 233.53 | -0.34 % | $ 23 B | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 12.0 | -1.32 % | $ 340 M | ||
|
Anixa Biosciences
ANIX
|
1.5 M | $ 3.15 | -6.81 % | $ 100 K | ||
|
Pacific Biosciences of California
PACB
|
2.28 B | $ 1.98 | 2.06 % | $ 502 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
14.5 B | $ 29.88 | 1.1 % | $ 20 B | ||
|
Personalis
PSNL
|
229 M | $ 8.57 | 5.86 % | $ 508 M | ||
|
Exact Sciences Corporation
EXAS
|
12.2 B | $ 102.08 | -0.03 % | $ 18.9 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | $ 47.69 | -1.25 % | $ 10.6 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 28.02 | 0.61 % | $ 847 M | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Charles River Laboratories International
CRL
|
12.4 B | $ 215.18 | -2.67 % | $ 11.1 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Mettler-Toledo International
MTD
|
33.2 B | $ 1 478.38 | -0.47 % | $ 31.4 B | ||
|
Thermo Fisher Scientific
TMO
|
202 B | $ 610.0 | -1.44 % | $ 233 B | ||
|
Trinity Biotech plc
TRIB
|
133 M | $ 0.73 | -1.14 % | $ 61.9 M | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.09 | -5.56 % | $ 1.97 B | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 38.47 | 8.92 % | $ 2.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 173.92 | -0.3 % | $ 19.3 B | ||
|
Biodesix
BDSX
|
142 M | $ 8.15 | 49.32 % | $ 1.06 B |